Keyphrases
Academic Hospital
6%
Acute Coronary Syndrome
8%
AIDS Patients
7%
AIDS/HIV
12%
Antibiotics
6%
Antiretroviral Therapy
5%
Apoptosis
6%
Arginine
5%
Birth Weight
5%
Body Mass Index
11%
Bovine Hydroxyapatite
5%
Bronchodilator
5%
Cell Damage
5%
Cesarean Section (C-section)
7%
Chronic Obstructive Pulmonary Disease
9%
Clinical Impact
5%
Core Needle Biopsy
5%
COVID-19
86%
COVID-19 Cases
6%
COVID-19 Infection
9%
COVID-19 Pandemic
10%
COVID-19 Patients
19%
COVID-19 Severity
5%
Drug Combination
5%
Drug Resistance mutations
5%
East Java
5%
Gestational Age
6%
Healthcare Workers
6%
Hospitalized Patients
6%
Human Immunodeficiency Virus Drug Resistance
5%
Human Immunodeficiency Virus Type 1 (HIV-1)
7%
Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome
5%
Hydroxychloroquine
9%
Hyperbilirubinemia
21%
Immunohistochemistry
6%
In Vitro Study
5%
Inclusion Criteria
6%
Indonesia
100%
Indonesian
21%
Intensive Care Unit
5%
Interleukin-17 (IL-17)
5%
Interleukin-6
9%
Interleukin-6 Expression
5%
Knee Osteoarthritis
10%
Large-for-gestational-age
5%
Lead Acetate
14%
Lopinavir
5%
Low Birth Weight
6%
Lung Tissue
5%
Male Infertility
8%
Malondialdehyde
6%
Maternal Lipid Levels
5%
Meta-analysis
19%
Ministry of Health
6%
Mortality Prediction
5%
Mouse Model
5%
Nanocurcumin
5%
Neonatal Hyperbilirubinemia
5%
Opportunistic Infections
5%
Osteoarthritis
6%
Ovarian Granulosa Cells
5%
Pediatric Residents
5%
Phototherapy
11%
Platform Trials
5%
Preeclampsia
11%
Pregnant Women
26%
Preterm Infants
6%
Protective Effect
5%
Protector
8%
Quantitative PCR
6%
Rattus Norvegicus
5%
Referral Hospital
5%
Resource-limited Settings
5%
Risk Factors
8%
Superoxide Dismutase
5%
Surabaya
50%
Systematic Meta-analysis
13%
Teaching Hospital
5%
Tertiary Referral Hospital
10%
Transcutaneous Bilirubin
5%
Universitas
6%
University Hospital
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acquired Immune Deficiency Syndrome
5%
Anti-Inflammatory Drug
6%
Antibiotics
8%
Arginine
5%
Asthma
6%
Bilirubin
11%
Biological Marker
5%
Bronchodilating Agent
5%
Chitosan
5%
Chronic Obstructive Lung Disease
5%
Combination Drug
5%
Coronavirinae
27%
Cross-Sectional Study
13%
Diabetes Mellitus
6%
Diseases
31%
Drug Resistance
10%
HIV
18%
Hydroxyapatite
8%
Hydroxychloroquine
10%
Hyperbilirubinemia
13%
Infection
31%
Inflammation
6%
Interleukin 6
14%
Lead Acetate
14%
Lopinavir Plus Ritonavir
5%
Low Birth Weight
5%
Male Infertility
8%
Mouse Model
5%
Neonatal Hyperbilirubinemia
5%
Opportunistic Infection
5%
Placebo
5%
Preeclampsia
8%
Prematurity
8%
Prevalence
18%
RNA Directed DNA Polymerase
7%
SARS Coronavirus
20%
Streptozotocin
5%
Medicine and Dentistry
Arginine
5%
Bilirubin
7%
Biological Marker
8%
Biopsy Technique
5%
Body Mass Index
6%
Cesarean Section
6%
Coronavirinae
5%
COVID-19
53%
Cross Sectional Study
11%
Drug Resistance
5%
Gestational Age
5%
Helicobacter Pylori
5%
HIV/AIDS
5%
Human Immunodeficiency Virus
5%
Hydroxylapatite
5%
Hyperbilirubinemia
20%
Infection
17%
Interleukin 6
5%
Large for Gestational Age
5%
Lymphocyte
5%
Male Infertility
5%
Meta-Analysis
8%
Neonatal Hyperbilirubinemia
5%
Neonatal Infant
13%
Observational Study
5%
Parenteral Nutrition
5%
Patient Referral
11%
Pediatrics
16%
Phototherapy
13%
Pre-Eclampsia
10%
Prematurity
8%
Prevalence
9%
Pulmonary Edema
6%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Systematic Review
11%